Insight on Pharmaceuticals and Healthcare in South Korea

Published within

« | 1 | » »|

Type Product title / description Pub Price
Report
Report

Orphan Drug Trends

Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.

Published By Datamonitor
25 Nov 2011 $2800
Buy
Report
Report

Pharmaceutical Licensing and Alliances in the Asia-Pacific Region

An overview of partnering trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q3 2010 to Q2 2011, with discussion of the drivers of recent deals and analysis of key deals and agreements in individual countries.

Published By Datamonitor
21 Dec 2011 $4800
Buy
Report
Report

Pharmaceutical Licensing and Alliances in the Asia-Pacific Region – Pharma enhances its focus on APAC markets

An overview of licensing and alliance trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q3 2009 to Q2 2010, including discussion of the drivers of recent deals and analysis of key agreements.

Published By Datamonitor
19 Nov 2010 $2800
Buy
Report
Report

Pharmaceutical M&A in the Asia Pacific Region

An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q1 2007 to Q2 2011, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.

Published By Datamonitor
24 Nov 2011 $4800
Buy
Report
Report

Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions

An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.

Published By Datamonitor
19 Aug 2010 $7600
Buy
Premium Report
Premium Report

Pharmaceuticals in South Korea - Industry and Country Analysis

Pharmaceuticals in South Korea - Industry and Country Analysis provides five forces Industry analysis, along with PESTLE country analysis of South Korea This report concludes with profiles of the leading companies in the Korean pharmaceuticals market

Published By Datamonitor
28 Jul 2011 $395
Buy
Report
Report

South Korea: Generics and Biosimilars Overview

This report provides an overview of the generics and biosimilars landscape in South Korea, including regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
08 Aug 2011 $1520
Buy
Report
Report

South Korea: Healthcare System and Drug Regulatory Overview

This report provides an overview of healthcare expenditure, the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in South Korea.

Published By Datamonitor
28 Jul 2011 $1520
Buy
Report
Report

South Korea: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in South Korea.

Published By Datamonitor
28 Jul 2011 $1520
Buy

« | 1 | » »|

No help is available.